// App-Quantinova.ai

P012 : Donor lymphocyte infusion (DLI) as salvage treatment for refractory or relapsed lymphoid malignancies after allogeneic stem cell transplantation: Experience from a single centre.

Researchers

Presenter

  • G. Martin Sanchez

Principal Investigators

  • A. Insunza

  • L. Yanez

  • E. Conde

  • A. Bermudez

  • M. Colorado

  • M. Lopez Duarte

  • C. Amunarriz

  • O. Irati

  • B. Lopez Pereira

  • C. Richard

  • J. L. Arroyo

Medical Centers

  • Banco de Sangre y Tejidos de Cantabria, Santander, Spain

  • Hospital Universitario Marques de Valdecilla,

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Acute lymphoblastic leukemia

  • Chronic Lymphocytic Leukemia

  • Graft-versus-host disease

  • Non-Hodgkin's Lymphoma

  • Hodgkin's Lymphoma

  • Multiple Myeloma

  • Non‐Hodgkin Lymphoma

  • Lymphomas

Biomarkers

  • Breakpoint Cluster Region

  • Cluster of Differentiation 2AP

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved